Skip to main content

Cutaneous Neoplasia and the Retinoids

  • Chapter
Retinoid Therapy
  • 93 Accesses

Abstract

There is much evidence from epidemiological studies,1 in vitro studies,2 and animal experiments3 that vitamin A and the retinoids reduce the probabability of cutaneous neoplasia. Furthermore, there are also reports suggesting that these drugs have an anti-neoplastic action as well. Basal cell carcinomata have been treated with moderate success with isotretinoin4 and etretinate.5 Multiple keratoacanthomata have been suppressed by isotretinoin,6 and encouraging results in the treatment of multiple solar keratoses have been reported.7

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kark, J., Smith, A. and Hames, C. (1982). Serum retinol and the inverse relationship between cholesterol and cancer. Br. Med. J., 284, 152

    Article  CAS  Google Scholar 

  2. Harisiadis, L., Miller, R., Hall, E. and Borek, C. (1978). A vitamin A analogue inhibits radiation induced autogenic transformation. Nature, (London), 274, 487

    Article  Google Scholar 

  3. Bollag, W. (1974). Therapeutic effect of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas in mice. Eur. J. Cancer, 10, 731

    Article  PubMed  CAS  Google Scholar 

  4. Peck, G., Gross, E., Butlaus, M. and De Giovanna, M. (1982). Chemoprevention of basal cell carcinoma with isotretinoin. J. Am. Acad. Dermatol., 6, 615

    Google Scholar 

  5. Beretti, B., Grupper, Ch., Edelsan, Y. and Bermejo, D. (1981). Aromatic retinoid in the treatment of multiple superficial basal cell carcinoma, arsenical keratoses and keratoacanthoma. In Orfanos, C.E. et al. (eds.). Retinoids: Advances in Basic Research and Therapy, pp. 397–400. (Berlin, Heidelberg, New York: Springer-Verlag)

    Google Scholar 

  6. Hayday, R., Reed, M., Dzubow, L. and Shuprek, J. (1980). Treatment of kerato-acanthomas with oral 13-cis-retinoic acid. TV. Engl. J. Med., 303, 560

    Article  Google Scholar 

  7. Moriarty, M., Dunn, J., Darragh, A., Lambe, R. and Brick, I. (1982). Etretinate in the treatment of actinic keratoses. Lancet, 1, 364

    Article  PubMed  CAS  Google Scholar 

  8. Chayen, J., Bittensky, L., Butcher, R. and Poulter, L. (1972). (eds.). A Guide to Practical Histochemistry, pp. 211–214. (Edinburgh: Oliver and Boyd)

    Google Scholar 

  9. Holt, S. (1958). Indigogenic staining methods for esterases. In Danielli, J. (ed.). General Cytochemical Methods, p.375. (New York: Academic Press)

    Google Scholar 

  10. Tsambaos, D. and Orfanos, C. (1981). Chemotherapy of psoriasis and other skin disorders with oral retinoids. Pharmacol. Ther., 14, 355

    Article  PubMed  CAS  Google Scholar 

  11. Fritsch, P., Nemanie, M. and Elias, P. (1982). Perturbations of membrane glycosylation in retinoid treated epidermis. J. Am. Acad. Dermatol, 6, 801

    Article  PubMed  Google Scholar 

  12. Bauer, R. and Orfanos, C.E. (1981). Influence of retinoid on human blood cells in vitro. TMMP retinoid inhibits the mutogenic properties of lectins and modulates the lymphocytic response. In Orfanos, C.E.et al. (eds.). Retinoids: Advances in Basic Research and Therapy, pp. 153–160. (Berlin, Heidelberg, New York: Springer-Verlag)

    Google Scholar 

  13. Hercend, Th., Bruley Rosset, M., Florentin, I. and Mathé, G. (1981). In vivo immunostimulatory properties of two retinoids: Ro 10-9359 and Ro 13-6298. In Orfanos, C.E. et al. (eds.). Retinoids: Advances in Basic Research and Therapy, pp. 21–30. (Berlin, Heidelberg, New York: Springer-Verlag)

    Google Scholar 

  14. Jurin, M. and Tannock, I. (1972). Influence of vitamin A on immunological response. Immunology, 23, 283

    PubMed  CAS  Google Scholar 

  15. Boutwell, R. (1982). Retinoids and inhibition of ornithine decarboxylase activity. J. Am. Acad. Dermatol., 6, 796

    Article  PubMed  CAS  Google Scholar 

  16. Kanerva, L., Niema, K., Lanharanta, J., Juvakoski, T. and Lassus, A. (1981). Electron microscopic characterisation of the mucous-like material before and after retinoid and retinoid-PUVA (RePUVA) treatment of psoriasis. In Orfanos, C.E. et al. (eds.). Retinoids: Advances in Basic Research and Therapy, pp. 467–472. (Berlin, Heidelberg, New York: Springer-Verlag)

    Google Scholar 

  17. Orfanos, C. (1982). Oral retinoid in psoriasis: current clinical experience and possible mechanisms of action. In Farber, E.M. et al. (eds.). Psoriasis, pp. 197–209. (New York: Grune & Stratton)

    Google Scholar 

Download references

Authors

Editor information

W. J. Cunliffe A. J. Miller

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Kingston, T., Marks, R. (1984). Cutaneous Neoplasia and the Retinoids. In: Cunliffe, W.J., Miller, A.J. (eds) Retinoid Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6349-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6349-1_21

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6351-4

  • Online ISBN: 978-94-011-6349-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics